EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Granulocyte and Monocyte Adsorptive Apheresis Maintenance Therapy Restored the Loss of Response to Anti‐ TNF ‐Alpha Agents in the Patients With UC : A Case Report

Nobuhiro Ueno iD, Yu Kobayashi, Aki Sakatani, Tatsuya Dokoshi, Keitaro Takahashi, Katsuyoshi Ando, Shin Kashima, Kentaro Moriichi, Hiroki Tanabe, Yuki Kamikokura, Mishie Tanino, Mikihiro Fujiya

Journal of Clinical Apheresis · 2025

DOI: 10.1002/jca.70030 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Apheresis, 2025. Verfasst von Nobuhiro Ueno und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan. Hauptthemen laut MEDLINE: Monocytes, Colitis, Ulcerative, Granulocytes, Blood Component Removal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammatory condition requiring lifelong management, with anti‐tumor necrosis factor α (anti‐TNF‐α) agents often used for refractory cases. However, secondary loss of response (LOR) to these agents, due to anti‐drug antibodies, poses a significant therapeutic challenge. This report describes a case where granulocyte and monocyte adsorptive apheresis (GMA) maintenance therapy successfully restored the efficacy of an anti‐TNF‐α agent in a 26‐year‐old male with active UC experiencing LOR to infliximab. Following GMA induction therapy and continued infliximab administration, clinical symptoms improved, fecal calprotectin levels decreased, and clinical remission was achieved. Long‐term maintenance with GMA enabled sustained clinical remission, with mucosal healing observed one year post‐therapy. This case suggests that GMA maintenance therapy may serve as a novel therapeutic approach for patients with active UC experiencing LOR to anti‐TNF‐α agents. However, further studies are warranted to elucidate the underlying mechanisms and validate its efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MonocytesColitis, UlcerativeGranulocytesBlood Component RemovalTumor Necrosis Factor-alphaInfliximabHumansMaleAdult

Stichwörter der Autor:innen

anti‐TNF‐α agentsgranulocyte and monocyte adsorptive apheresis (GMA)loss of responsemaintenance therapyulcerative colitis

Substanzen

Tumor Necrosis Factor-alphaInfliximab

Autor:innen und Institutionen

  • Department of General Medicine, Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan.
  • Department of Gastroenterological Sciences, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
  • Division of Gastroenterology, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
  • Department of Diagnostic Pathology, Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan.

ORCID-Profile: Nobuhiro Ueno

Zitieren

APA

Ueno, N., Kobayashi, Y., Sakatani, A., Dokoshi, T., Takahashi, K., Ando, K., Kashima, S., Moriichi, K., Tanabe, H., Kamikokura, Y., Tanino, M., & Fujiya, M. (2025). Granulocyte and Monocyte Adsorptive Apheresis Maintenance Therapy Restored the Loss of Response to Anti‐ TNF ‐Alpha Agents in the Patients With UC : A Case Report. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70030

Vancouver

Ueno N, Kobayashi Y, Sakatani A, Dokoshi T, Takahashi K, Ando K, et al. Granulocyte and Monocyte Adsorptive Apheresis Maintenance Therapy Restored the Loss of Response to Anti‐ TNF ‐Alpha Agents in the Patients With UC : A Case Report. Journal of Clinical Apheresis. 2025. doi:10.1002/jca.70030

BibTeX
@article{Ueno2025,
  author = {Ueno, Nobuhiro and Kobayashi, Yu and Sakatani, Aki and Dokoshi, Tatsuya and Takahashi, Keitaro and Ando, Katsuyoshi and Kashima, Shin and Moriichi, Kentaro and Tanabe, Hiroki and Kamikokura, Yuki and Tanino, Mishie and Fujiya, Mikihiro},
  title = {Granulocyte and Monocyte Adsorptive Apheresis Maintenance Therapy Restored the Loss of Response to Anti‐ TNF ‐Alpha Agents in the Patients With UC : A Case Report},
  journal = {Journal of Clinical Apheresis},
  year = {2025},
  doi = {10.1002/jca.70030}
}
Kostenlos starten →